Delivery of evidence-based treatment for multiple anxiety disorders in primary care: A randomized controlled trial

JAMA

Volumn 303, Issue 19, 2010, Pages 1921-1928

  Roy Byrne, Peter ^a   Craske, Michelle G ^b   Sullivan, Greer ^c,d,h   Rose, Raphael D ^b   Edlund, Mark J ^c   Lang, Ariel J ^e,g   Bystritsky, Alexander ^b   Welch, Stacy Shaw ^a   Chavira, Denise A ^e   Golinelli, Daniela ^h   Campbell Sills, Laura ^e   Sherbourne, Cathy D ^h   Stein, Murray B ^e,f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^h RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; BRIEF SYMPTOM INVENTORY; CLINICAL TRIAL; COGNITIVE THERAPY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GENERALIZED ANXIETY DISORDER; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PANIC; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SOCIAL PHOBIA; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 77952356171     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.608     Document Type: Article

References (40)

1. Westfall JM, Mold J, Fagnan L. Practice-based research: "Blue Highways" on the NIH roadmap. JAMA. 2007;297(4):403-406.
2. Unützer J, Katon W, Callahan CM, et al; IMPACT Investigators. Improving Mood-Promoting Access to Collaborative Treatment. Collaborative care management of late-life depression in the primary care setting. JAMA. 2002;288(22):2836-2845.
3. Wells KB, Sherbourne CD, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000;283(2):212-220. (Pubitemid 30039221)
4. Simon GE, VonKorff M, Rutter C, Wagner E. Randomized trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320(7234):550-554. (Pubitemid 30175801)
5. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53(10):924-932. (Pubitemid 26358007)
6. Roy-Byrne PP, Craske MG, Stein MB, et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 2005;62(3):290-298. (Pubitemid 40990974)
7. Rollman BL, Belnap BH, Mazumdar S, et al. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry. 2005;62(12):1332-1341. (Pubitemid 41748283)
8. Stein MB, Sherbourne CD, Craske MG, et al. Quality of care for primary care patients with anxiety disorders. Am J Psychiatry. 2004;161(12):2230-2237. (Pubitemid 39587288)
9. Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry. 2002;59(1):77-84. (Pubitemid 34044410)
10. Grilo CM, Money R, Barlow DH, et al. Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry. 1998;39(6):323-332. (Pubitemid 28523446)
11. Hazlett-Stevens H, Craske MG, Roy-Byrne PP, Sherbourne CD, Stein MB, Bystritsky A. Predictors of willingness to consider medication and psychosocial treatment for panic disorder in primary care patients. Gen Hosp Psychiatry. 2002;24(5):316-321. (Pubitemid 36151667)
12. Nadiga DN, Hensley PL, Uhlenhuth EH. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Depress Anxiety. 2003;17(2):58-64.
13. Heuzenroeder L, Donnelly M, Haby MM, et al. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Aust N Z J Psychiatry. 2004;38(8):602-612. (Pubitemid 39199487)
14. Sullivan G, Craske MG, Sherbourne C, et al. Design of the Coordinated Anxiety Learning and Management (CALM) study: innovations in collaborative care for anxiety disorders. Gen Hosp Psychiatry. 2007; 29(5):379-387.
15. Chilvers C, Dewey M, Fielding K, et al; Counselling versus Antidepressants in Primary Care Study Group. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ. 2001;322(7289):772-775.
16. Unützer J, Choi Y, Cook IA, Oishi S. A web-based data management system to improve care for depression in amulticenter clinical trial. Psychiatr Serv. 2002;53(6):671-673, 678.
17. Craske MG, Rose RD, Lang A, et al. Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settings. Depress Anxiety. 2009;26(3):235-242.
18. Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, Craske MG, Stein MB.Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the Anxiety and Depression Detector. Gen Hosp Psychiatry. 2006;28(2):108-118.
19. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57.
20. Campbell-Sills L, Norman SB, Craske MG, et al. Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS). J Affect Disord. 2009;112(1-3):92-101.
21. Roy-Byrne P, Veitengruber JP, Bystritsky A, et al. Brief intervention for anxiety in primary care patients. J Am Board Fam Med. 2009;22(2):175-186.
22. Tsao JC, Mystkowski JL, Zucker BG, Craske MG. Impact of cognitive-behavioral therapy for panic disorder on comorbidity: a controlled investigation. Behav Res Ther. 2005;43(7):959-970. (Pubitemid 40719615)
23. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17-31.
24. Weissman MM, Verdeli H, Gameroff MJ, et al. National survey of psychotherapy training in psychiatry, psychology, and social work. Arch Gen Psychiatry. 2006;63(8):925-934. (Pubitemid 44188485)
25. Derogatis L. BSI-18: Brief Symptom Inventory 18 Administration, Scoring, and Procedures Manual. Minneapolis, MN: NCS Pearson Inc; 2001.
26. Simon GE, Katon WJ, VonKorff M, et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry. 2001;158(10):1638-1644. (Pubitemid 32923656)
27. Kroenke K, Spitzer RL,Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
28. Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the predictions of fearfulness. Behav Res Ther. 1986;24(1):1-8.
29. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(suppl 3):89-95.
30. Centers for Disease Control and Prevention. Measuring Healthy Days. Atlanta, GA: Centers for Disease Control and Prevention; 2000.
31. Ware JE Jr, Kosinski M, Bowker D, Gandek B. How to Score Version 2 of the SF-12 Health Survey (With a Supplement Documenting Version 1). Lincoln, RI: Quality Metric Inc; 2002.
32. Steketee G, Perry JC, Goisman RM, et al. The psychosocial treatments interview for anxiety disorders: a method for assessing psychotherapeutic procedures in anxiety disorders. J Psychother Pract Res. 1997;6(3):194-210.
33. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute Inc; 1996.
34. Little R, Rubin D. Statistical Analysis With Missing Data. New York, NY: John Wiley & Sons; 1987.
35. Brick JM, Kalton G. Handling missing data in survey research. Stat Methods Med Res. 1996;5(3):215-238.
36. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75(4):800-802.
37. Nuovo J, Melnikow J, Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA. 2002;287(21):2813-2814.
38. Moore A. What is a number needed to treat? http://www.medicine.ox.ac.uk/ bandolier/painres/download/whatis/NNT.pdf. Accessed December 1, 2009.
39. Feeny NC, Zoellner LA, Mavissakalian MR, Roy-Byrne PP. What would you choose? sertraline or prolonged exposure in community and PTSD treatment seeking women. Depress Anxiety. 2009;26(8):724-731.
40. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627. (Pubitemid 40973437)